Products

Liraglutide

Product Information

Cat #

MFTP-139

CAS No.

204656-20-2

Enzyme Commission Number

Product Overview

Liraglutide is a once-daily injectable derivative of the human incretin glucagon-like peptide-1 (GLP-1), for the treatment of type 2 diabetes or obesity.

Features

Ready-to-use product, accelerating research progress, enhancing application performance.

Method

Technology

Synonyms

Type

Function

Applications

Pharmaceutical Industry

Storage

Storage Buffer

Shelf Life

Strains

Escherichia coli

Source

Appearance

Molecular Weight

Color / Form

Instruction

Enzyme Class

Production Methods

Fermentation

Activity

Specific Enzyme Activity

Purity

98%(HPLC)

Unit Definition

Amino Acids Sequence

WARNINGS

Shipping

Timely shipping by optional means

Formula

Reaction

Recommendation

Species Reactivity

Contents

Compatibility

Melting Point

Final Titre

≥5g/L

Fermentation Time

10-16hrs

Recovery Yield

Starting Material

Specification

Standard and Custom Specifications

Substrates

Concentration

Usage And Dosage

Description

Liraglutide is a derivative of a human incretin (metabolic hormone), glucagon-like peptide-1 (GLP-1) that is used as a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion.

For Research Use Only.

Have a question? Get a Free Consultation